3min chapter

Oncotarget cover image

HER3: A Vital Target in Cancer Treatment

Oncotarget

CHAPTER

Challenges in Translating Preclinical Studies on HER3 Targeted Therapies to Clinical Trials

Exploring the challenges in translating preclinical studies on HER3 targeted therapies to clinical trials, including the lack of HER3 expression screening in previous trials. Emphasizing the importance of identifying HER3 expression and gene fusions as predictive biomarkers and discussing alternative HER3 activating mechanisms and compensatory tumor cell responses.

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode